المنشورات طباعة Mangioris G, Pittock SJ, Yang B, Fryer JP, Harmsen WS, Dubey D, Flanagan EP, Lopez-Chiriboga SA, McKeon A, Mills JR, Vodopivec I, Tobin WO, Toledano M, Aksamit AJ, Zekeridou A. Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights. Ann Neurol. 2024 Jul 19 Epub 2024 July 19 View PubMed Paul P, Campbell G, Zekeridou A, Mauermann M, Naddaf E. Diagnosing Peripheral Neuropathy in Patients With Alcohol Use Disorder. Mayo Clin Proc. 2024 Jul 5 Epub 2024 July 05 View PubMed Syc-Mazurek SB, Zhao-Fleming H, Guo Y, Tisavipat N, Chen JJ, Zekeridou A, Kournoutas I, Orme JJ, Block MS, Lucchinetti CF, Mustafa R, Flanagan EP. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use. Neurol Neuroimmunol Neuroinflamm. 2024 Jul; 11 (4):e200249 Epub 2024 May 02 View PubMed Gilligan M, Lesnick CE, Guo Y, Bradshaw MJ, Ladha SS, Nowak M, Shah MP, Wittenborn JR, Basal E, Hinson S, Yang B, Dubey D, Mills JR, Pittock SJ, Zekeridou A, McKeon A. Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis. Ann Neurol. 2024 Jul; 96 (1):21-33 Epub 2024 Apr 18 View PubMed Redenbaugh V, Fryer JP, Cacciaguerra L, Chen JJ, Greenwood TM, Gilligan M, Thakolwiboon S, Majed M, Chia NH, McKeon A, Mills JR, Lopez Chiriboga AS, Tillema JM, Yang B, Abdulrahman Y, Guo K, Vorasoot N, Valencia Sanchez C, Tajfirouz DA, Toledano M, Zekeridou A, Dubey D, Gombolay GY, Caparo-Zamalloa C, Kister I, Pittock SJ, Flanagan EP. Diagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid. Ann Neurol. 2024 Jul; 96 (1):34-45 Epub 2024 Apr 09 View PubMed Segal Y, Zekeridou A. Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery. Curr Opin Neurol. 2024 Jun 1; 37 (3):295-304 Epub 2024 Mar 26 View PubMed Mangioris G, Halfdanarson TR, Lennon VA, Chang BK, Dubey D, Dyck PJB, Flanagan EP, McKeon A, Mills JR, Pittock SJ, Zekeridou A. Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles. Eur J Neurol. 2024 Jun; 31 (6):e16273 Epub 2024 Mar 11 View PubMed Li X, Gupta P, Smith KM, Madhavan A, Rezk M, Zekeridou A, Flanagan EP, McKeon A, Pittock SJ, Britton JW, Dubey D. Seizure-Related Falls and Near Falls in LGI1-IgG Autoimmune Encephalitis. Neurol Clin Pract. 2024 Jun; 14 (3):e200301 Epub 2024 May 07 View PubMed Aboseif A, Vorasoot N, Pinto MV, Guo Y, Hasan S, Zekeridou A, Chen JJ, Dubey D. Immune Checkpoint Inhibitor-Associated Kelch-Like Protein-11 IgG Brainstem Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2024 May; 11 (3):e200218 Epub 2024 Mar 14 View PubMed Li X, Chen JJ, Hur M, Paton GR, McKeon A, Zekeridou A. Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype. J Neuroimmunol. 2024 Mar 15; 388:578312 Epub 2024 Feb 05 View PubMed Thakolwiboon S, Linnoila J, Pittock SJ, Dubey D, Zekeridou A. Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome. J Neuroimmunol. 2024 Feb 15; 387:578293 Epub 2024 Jan 19 View PubMed Guo Y, Endmayr V, Zekeridou A, McKeon A, Leypoldt F, Hess K, Kalinowska-Lyszczarz A, Klang A, Pakozdy A, Hoftberger E, Hametner S, Haider C, De Simoni D, Peters S, Gelpi E, Rocken C, Oberndorfer S, Lassmann H, Lucchinetti CF, Hoftberger R. New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis. Acta Neuropathol. 2024 Feb 3; 147 (1):31 Epub 2024 Feb 03 View PubMed McCombe JA, Sechi E, Zekeridou A. Neurologic manifestations of autoimmunity with immune checkpoint inhibitors. Handb Clin Neurol. 2024; 200:449-465 View PubMed Farina A, Villagran-Garcia M, Vogrig A, Zekeridou A, Muniz-Castrillo S, Velasco R, Guidon AC, Joubert B, Honnorat J. Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes. Lancet Neurol. 2024 Jan; 23 (1):81-94 View PubMed Mathias A, Perriot S, Jones S, Canales M, Bernard-Valnet R, Gimenez M, Torcida N, Oberholster L, Hottinger AF, Zekeridou A, Theaudin M, Pot C, Du Pasquier R. Human stem cell-derived neurons and astrocytes to detect novel auto-reactive IgG response in immune-mediated neurological diseases. Front Immunol. 2024; 15:1419712 Epub 2024 July 24 View PubMed Bartley CM, Ngo TT, Do LD, Zekeridou A, Dandekar R, Muniz-Castrillo S, Alvarenga BD, Zorn KC, Tubati A, Pinto AL, Browne WD, Hullett PW, Terrelonge M, Schubert RD, Piquet AL, Yang B, Montalvo Perero MJ, Montalvo M, Kung AF, Mann SA, Shah MP, Geschwind MD, Gelfand JM, DeRisi JL, Pittock SJ, Honnorat J, Pleasure SJ, Wilson MR. Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins. Ann Neurol. 2023 Dec; 94 (6):1086-1101 Epub 2023 Sept 19 View PubMed Li X, Krecke KN, Weinshenker BG, Clarke MJ, Zekeridou A, Toledano M, Flanagan EP. Hemicord White Matter Enhancement and the Croissant Sign in Cervical Spondylotic Myelopathy. Neurology. 2023 Nov 21; 101 (21):968-969 Epub 2023 Aug 30 View PubMed McKeon A, Lesnick C, Vorasoot N, Buckley MW, Dasari S, Flanagan EP, Gilligan M, Lafrance-Corey R, Miske R, Pittock SJ, Scharf M, Yang B, Zekeridou A, Dubey D, Mills J. Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease. Neurol Neuroimmunol Neuroinflamm. 2023 Sep; 10 (5) Epub 2023 Aug 07 View PubMed Smith KM, Britton JW, Thakolwiboon S, Chia NH, Gupta P, Flanagan EP, Zekeridou A, Lopez Chiriboga AS, Valencia Sanchez C, McKeon A, Pittock SJ, Dubey D. Seizure characteristics and outcomes in patients with neurological conditions related to high-risk paraneoplastic antibodies. Epilepsia. 2023 Sep; 64 (9):2385-2398 Epub 2023 July 04 View PubMed Yang B, Brown A, McKeon A, Ahlskog JE, Tipton P, Guo Y, Lucchinetti C, Pittock SJ, Zekeridou A. Tenascin-R Autoimmunity: Isolated Tremor Reversed with Immunotherapy. Ann Neurol. 2023 Sep; 94 (3):502-507 Epub 2023 July 14 View PubMed Valencia-Sanchez C, Sechi E, Dubey D, Flanagan EP, McKeon A, Pittock SJ, Zekeridou A. Immune checkpoint inhibitor-associated central nervous system autoimmunity. Eur J Neurol. 2023 Aug; 30 (8):2418-2429 Epub 2023 May 18 View PubMed Chia NH, McKeon A, Dalakas MC, Flanagan EP, Bower JH, Klassen BT, Dubey D, Zalewski NL, Duffy D, Pittock SJ, Zekeridou A. Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria. Ann Clin Transl Neurol. 2023 Jul; 10 (7):1083-1094 Epub 2023 May 22 View PubMed Orozco E, Valencia-Sanchez C, Britton J, Dubey D, Flanagan EP, Lopez-Chiriboga AS, Zalewski N, Zekeridou A, Pittock SJ, McKeon A. Autoimmune Encephalitis Criteria in Clinical Practice. Neurol Clin Pract. 2023 Jun; 13(3):e200151. Epub 2023 Apr 25. View PubMed McCombe JA, Zivelonghi C, Vorasoot N, Majed M, Flanagan EP, Dubey D, Pittock SJ, McKeon A, Zekeridou A. AMPAR autoimmunity: Neurological and oncological accompaniments and co-existing neural autoantibodies. J Neuroimmunol. 2023 Feb 15; 375:578012 Epub 2022 Dec 23 View PubMed Vorasoot N, Scharf M, Miske R, Thakolwiboon S, Dubey D, Mills JR, Pittock SJ, Zekeridou A, Ott A, McKeon A. CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity. Front Immunol. 2023; 14:1265797 Epub 2023 Sept 29 View PubMed Rezk M, Pittock SJ, Kapadia RK, Knight AM, Guo Y, Gupta P, LaFrance-Corey RG, Zekeridou A, McKeon A, Dasari S, Mills JR, Dubey D. Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome. Front Immunol. 2023; 14:1243946 Epub 2023 Sept 18 View PubMed Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 Jan 1; 80 (1):30-39 View PubMed Shelly S, Beecher G, Milone M, Liewluck T, Ernste F, Triplett J, Naddaf E, Zekeridou A, McKeon A, Pittock SJ, Dubey D, Mills JR, Mandrekar J, Klein CJ. Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluation. Rheumatology (Oxford). 2022 Dec 23; 62 (1):281-289 View PubMed Sista SR, Crum B, Aboseif A, Devine MF, Zekeridou A, Hammami MB, Rezk MM, Truffert A, Lalive PH, Kunchok A, McKeon A, Dubey D. Motor-neuron-disease-like phenotype associated with IgLON5 disease. J Neurol. 2022 Nov; 269(11):6139-6144. Epub 2022 Jul 20. View PubMed Klein CJ, Beecher G, Lamb C, Naddaf E, Milone M, Liewluck T, Dubey D, Zekeridou A, Shelly S, Mills JR. LRP4-IgG service line testing in seronegative myasthenia gravis and controls. J Neuroimmunol. 2022 Jul 15; 368:577895 Epub 2022 May 18 View PubMed McKeon-Makki I, McKeon A, Yang B, Pittock SJ, Lopez-Chiriboga S, Komorowski L, Miske R, Zekeridou A. Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients. J Neuroimmunol. 2022 Jun 15; 367:577861. Epub 2022 Apr 04. View PubMed Zekeridou A, Yang B, Lennon VA, Guo Y, Wu L, Lucchinetti CF, McKeon A, Pittock SJ, Flanagan EP. Anti-Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1. Ann Neurol. 2022 May; 91 (5):670-675 Epub 2022 Mar 03 View PubMed Kunchok A, McKeon A, Zekeridou A, Flanagan EP, Dubey D, Lennon VA, Klein CJ, Mills JR, Pittock SJ. Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations. Mayo Clin Proc. 2022 Mar; 97 (3):547-559 Epub 2021 Dec 23 View PubMed Garrido Sanabria ER, Zahid A, Britton J, Kraus GJ, Lopez-Chiriboga AS, Zekeridou A, Flanagan EP, McKeon A, Mills JR, Pittock SJ, Dubey D. CASPR2-IgG-associated autoimmune seizures. Epilepsia. 2022 Mar; 63 (3):709-722 Epub 2022 Jan 15 View PubMed Rodriguez A, Klein CJ, Sechi E, Alden E, Basso MR, Pudumjee S, Pittock SJ, McKeon A, Britton JW, Lopez-Chiriboga AS, Zekeridou A, Zalewski NL, Boeve BF, Day GS, Gadoth A, Burkholder D, Toledano M, Dubey D, Flanagan EP. LGI1 antibody encephalitis: acute treatment comparisons and outcome. J Neurol Neurosurg Psychiatry. 2022 Mar; 93 (3):309-315 Epub 2021 Nov 25 View PubMed Chompoopong P, Zekeridou A, Shelly S, Ruff M, Dyck PJ, Klein CJ, Pittock SJ, Mauermann M, Dubey D. Comparison of immune checkpoint inhibitor-related neuropathies among patients with neuroendocrine and non-neuroendocrine tumours. J Neurol Neurosurg Psychiatry 2022 Jan; 93 (1):112-114 Epub 2021 May 26 View PubMed Pittock SJ, Zekeridou A, Weinshenker BG. Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials. Nat Rev Neurol. 2021 Dec; 17 (12):759-773 Epub 2021 Oct 28 View PubMed Sun MM, Seleme N, Chen JJ, Zekeridou A, Sechi E, Walsh RD, Beebe JD, Sabbagh O, Mejico LJ, Gratton S, Skidd PM, Bellows DA, Falardeau J, Fraser CL, Cappelen-Smith C, Haines SR, Hassanzadeh B, Seay MD, Subramanian PS, Williams Z, Gordon LK. Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade. J Neuroophthalmol. 2021 Dec 1; 41 (4):519-530 View PubMed Pilotto A, Masciocchi S, Volonghi I, De Giuli V, Caprioli F, Mariotto S, Ferrari S, Bozzetti S, Imarisio A, Risi B, Premi E, Benussi A, Foca E, Castelli F, Zanusso G, Monaco S, Stefanelli P, Gasparotti R, Zekeridou A, McKeon A, Ashton NJ, BlennoW K, Zetterberg H, Padovani A. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses. Clin Infect Dis. 2021 Nov 2; 73 (9):e3019-e3026 View PubMed Maniscalco GT, Zekeridou A, Allegorico L, Ranieri A, Napolitano M, Pezzella M, Gatta LD, Manzo V, Ferrari S, Mariotto S. GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation. Neurol Sci. 2021 Oct; 42 (10):4289-4291 Epub 2021 May 11 View PubMed Shelly S, Mills JR, Dubey D, McKeon A, Zekeridou A, Pittock SJ, Harper CM, Naddaf E, Milone M, Mandrekar J, Klein CJ. Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels. Neurology. 2021 Jun 14; 96 (24):e2966-e2976 Epub 2021 June 14 View PubMed Zivelonghi C, Zekeridou A. Neurological complications of immune checkpoint inhibitor cancer immunotherapy. J Neurol Sci. 2021 May 15; 424:117424 Epub 2021 Mar 27 View PubMed Kong Y, McKeon A, Koh OSQ, Chiew YR, Purohit B, Chin CF, Zekeridou A, Ng ASL. Teaching NeuroImages: Linear Radial Periventricular Enhancement in Glial Fibrillary Acidic Protein Astrocytopathy. Neurology. 2021 May 11; 96 (19):e2454-e2455 Epub 2021 Jan 06 View PubMed Taraschenko O, Fox HS, Zekeridou A, Pittock SJ, Eldridge E, Farukhuddin F, Al-Saleem F, Devi Kattala C, Dessain SK, Casale G, Willcockson G, Dingledine R. Seizures and memory impairment induced by patient-derived anti-N-methyl-D-aspartate receptor antibodies in mice are attenuated by anakinra, an interleukin-1 receptor antagonist. Epilepsia. 2021 Mar; 62 (3):671-682 Epub 2021 Feb 17 View PubMed Sechi E, Zekeridou A. Neurologic Complications of Immune Checkpoint Inhibitors in Thoracic Malignancies. J Thorac Oncol. 2021 Mar; 16 (3):381-394 Epub 2020 Nov 11 View PubMed Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, Shah SS, Gadoth A, Naddaf E, McKeon A, Pittock SJ, Zalewski NL. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021 Feb 9; 92 (6):645-54 Epub 2021 Feb 09 View PubMed McKeon A, Shelly S, Zivelonghi C, Basal E, Dubey D, Flanagan E, Madhavan AA, Mariotto S, Toledano M, Tracy JA, Zekeridou A, Pittock SJ. Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers. Ann Clin Transl Neurol. 2021 Feb; 8 (2):425-439 Epub 2020 Dec 28 View PubMed Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, Dubey D, Flanagan EP, Lopez-Chiriboga S, Trenerry MR, Zalewski NL, Zekeridou A, McKeon A. Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun. 2021; 3 (2):fcaa233 Epub 2021 Jan 05 View PubMed Valencia-Sanchez C, Zekeridou A. Paraneoplastic Neurological Syndromes and Beyond Emerging With the Introduction of Immune Checkpoint Inhibitor Cancer Immunotherapy. Front Neurol. 2021; 12:642800. Epub 2021 Apr 09. View PubMed Shelly S, Paul P, Bi H, Dubey D, Milone M, Sorenson EJ, Crum BA, Laughlin RS, Liewluck T, Mandrekar J, Pittock SJ, Zekeridou A, McKeon A, Harper MC, Mills JR, Klein CJ. Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm. Neurology. 2020 Dec 1; 95 (22):e3002-e3011 Epub 2020 Sept 16 View PubMed Budhram A, Britton JW, Liebo GB, Dubey D, Zekeridou A, Flanagan EP, McKeon A, Pittock SJ, Braksick SA, Zalewski NL. Use of diffusion-weighted imaging to distinguish seizure-related change from limbic encephalitis. J Neurol. 2020 Nov; 267 (11):3337-3342 Epub 2020 June 24 View PubMed McKeon A, Zekeridou A. Autoimmune encephalitis management: MS centers and beyond. Mult Scler. 2020 Nov; 26 (13):1618-1626 Epub 2020 Feb 13 View PubMed Dubey D, Wilson MR, Clarkson B, Giannini C, Gandhi M, Cheville J, Lennon VA, Eggers S, Devine MF, Mandel-Brehm C, Kryzer T, Hinson SR, Khazaie K, Hales C, Kattah J, Pavelko KD, Andrews P, Eaton JE, Jitprapaikulsan J, Mills JR, Flanagan EP, Zekeridou A, Leibovich B, Fryer J, Torre M, Kaufman C, Thoreson JB, Sagen J, Linnoila JJ, DeRisi JL, Howe CL, McKeon A, Pittock SJ. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol. 2020 Nov 1; 77 (11):1420-1429 View PubMed Sechi E, Markovic SN, McKeon A, Dubey D, Liewluck T, Lennon VA, Lopez-Chiriboga AS, Klein CJ, Mauermann M, Pittock SJ, Flanagan EP, Zekeridou A. Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes. Neurology. 2020 Oct 27; 95 (17):e2442-e2452 Epub 2020 Aug 13 View PubMed Dubey D, Britton J, McKeon A, Gadoth A, Zekeridou A, Lopez Chiriboga SA, Devine M, Cerhan JH, Dunlay K, Sagen J, Ramberger M, Waters P, Irani SR, Pittock SJ. Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy. Ann Neurol. 2020 Feb; 87 (2):313-323 Epub 2019 Dec 14 View PubMed Kunchok A, Zekeridou A, Pittock S. CRMP5-IgG-Associated Paraneoplastic Myelopathy With PD-L1 Inhibitor Therapy. JAMA Neurol. 2020 Feb 1; 77 (2):255-256 View PubMed O'Donovan B, Mandel-Brehm C, Vazquez SE, Liu J, Parent AV, Anderson MS, Kassimatis T, Zekeridou A, Hauser SL, Pittock SJ, Chow E, Wilson MR, DeRisi JL. High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display. Brain Commun. 2020; 2 (2):fcaa059 Epub 2020 Aug 03 View PubMed Zhu M, Ma Y, Zekeridou A, Lennon VA. Case Report: Innate Immune System Challenge Unleashes Paraneoplastic Neurological Autoimmunity. Front Neurol. 2020; 11:598894 Epub 2020 Dec 10 View PubMed Shelly S, Triplett JD, Pinto MV, Milone M, Diehn FE, Zekeridou A, Liewluck T. Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy. Brain Commun. 2020; 2 (2):fcaa181 Epub 2020 Nov 02 View PubMed Zekeridou A, Lennon VA. Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy. Mayo Clin Proc. 2019 Sep; 94 (9):1865-1878 Epub 2019 July 26 View PubMed Zekeridou A, Kryzer T, Guo Y, Hassan A, Lennon V, Lucchinetti CF, Pittock S, McKeon A. Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity. Neurology. 2019 Aug 20; 93 (8):e815-e822 Epub 2019 July 17 View PubMed Daneshmand A, Goyal G, Markovic S, Zekeridou A, Wijdicks EFM, Hocker SE. Autoimmune Encephalitis Secondary to Melanoma. Ann Intern Med 2019 Jun 18; 170 (12):905-906 Epub 2019 Feb 12 View PubMed Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol. 2019 Jun; 32 (3):452-458 View PubMed O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A. GABAA receptor autoimmunity: A multicenter experience. Neurol Neuroimmunol Neuroinflamm. 2019 May; 6 (3):e552 Epub 2019 Apr 04 View PubMed Zekeridou A, Majed M, Heliopoulos I, Lennon VA. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments. Thorac Cancer. 2019 Apr; 10 (4):1001-1004 Epub 2019 Feb 27 View PubMed Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, Aksamit AJ, Krecke KN, Kaufmann TJ, Jolliffe EA, Zalewski NL, Zekeridou A, Wingerchuk DM, Jitprapaikulsan J, Flanagan EP. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis. J Neurol Neurosurg Psychiatry 2019 Apr; 90 (4):488-490 Epub 2018 July 21 View PubMed Taraschenko O, Fox HS, Pittock SJ, Zekeridou A, Gafurova M, Eldridge E, Liu J, Dravid SM, Dingledine R. A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis. Epilepsia. 2019 Mar; 60 (3):452-463 Epub 2019 Feb 11 View PubMed Mammen AL, Rajan A, Pak K, Lehky T, Casciola-Rosen L, Donahue RN, Lepone LM, Zekeridou A, Pittock SJ, Hassan R, Schlom J, Gulley JL. Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1. Ann Rheum Dis 2019 Jan; 78 (1):150-152 Epub 2018 Sept 05 View PubMed Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, Hogan WJ, Poterucha JJ, Wilton KM, Lin Y, Flanagan EP. Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5(6):e497. Epub 2018 Aug 20. View PubMed Zekeridou A, Griesmann GE, Lennon VA. Mutated cancer autoantigen implicated cause of paraneoplastic myasthenia gravis. Muscle Nerve. 2018 Oct; 58 (4):600-604 Epub 2018 Aug 23 View PubMed Lopez-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ. LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol. 2018 Sep; 84 (3):473-480 View PubMed Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A. Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1year. J Neuroimmunol. 2018 Aug 15; 321:157-163 Epub 2018 Apr 27 View PubMed Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ. Elevated LGI1-IgG CSF index predicts worse neurological outcome. Ann Clin Transl Neurol. 2018 May; 5 (5):646-650 Epub 2018 Apr 02 View PubMed Zekeridou A, McKeon A, Lennon VA. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma. JAMA Neurol. 2016 Jul 1; 73 (7):853-9 View PubMed Zekeridou A, Ferfoglia RI, Du Pasquier R, Lalive PH. [Paraneoplastic neurological syndromes: an update]. Rev Med Suisse. 2016 Apr 27; 12 (516):832-4, 836-9 View PubMed Joubert B, Kerschen P, Zekeridou A, Desestret V, Rogemond V, Chaffois MO, Ducray F, Larrue V, Daubail B, Idbaih A, Psimaras D, Antoine JC, Delattre JY, Honnorat J. Clinical Spectrum of Encephalitis Associated With Antibodies Against the alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature. JAMA Neurol. 2015 Oct; 72 (10):1163-9 View PubMed Zekeridou A, Michel P, Medlin F, Hayoz D, Lalive PH, Kuntzer T. Successful long-term ambulatory norepinephrine infusions in a patient with pure autonomic failure. Clin Auton Res. 2015 Aug; 25 (4):251-3 Epub 2015 July 03 View PubMed Zekeridou A, Lennon VA. Aquaporin-4 autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2 (4):e110 Epub 2015 May 21 View PubMed Zekeridou A, Karantoni E, Viaccoz A, Ducray F, Gitiaux C, Villega F, Deiva K, Rogemond V, Mathias E, Picard G, Tardieu M, Antoine JC, Delattre JY, Honnorat J. Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis. J Neurol. 2015 Aug; 262 (8):1859-66 Epub 2015 May 19 View PubMed Rossel T, Zekeridou A, Ochsner F, Renaud S. Aquaporin-4-positive myelitis associated with Sjogren syndrome and colonic adenocarcinoma. Neurol Neuroimmunol Neuroinflamm. 2015 Jun; 2 (3):e103 Epub 2015 Apr 09 View PubMed Chabwine JN, Tschirren MV, Zekeridou A, Landis BN, Kuntzer T. Sweet taste loss in myasthenia gravis: more than a coincidence? Orphanet J Rare Dis 2014 Apr 11; 9:50 View PubMed Medlin F, Zekeridou A, Renaud S, Kuntzer T. Favorable outcome of an acute complex regional pain syndrome with immunoglobulin infusions. Clin J Pain. 2013 Nov; 29 (11):e33-4 View PubMed Zekeridou A, Rossetti AO, Hottinger AF, Du Pasquier RA. [Anti-neuronal antibodies: a rapidly developing field]. Rev Med Suisse. 2013 May 1; 9 (384):909-14 View PubMed Gschwind M, Binaghi S, Zekeridou A, Michel P. Neurological picture. Dispersion and 'salted pretzel sign' from thrombolysis of a spontaneous calcified embolus in an acute stroke. J Neurol Neurosurg Psychiatry. 2013 Jan; 84 (1):111-2 Epub 2012 Aug 09 View PubMed Zekeridou A, Ochsner F, Medlin F, Lobrinus JA, Becce F, Kuntzer T. Schwannoma of the palmar cutaneous nerve: electrodiagnosis with radiologic and pathologic correlations. Arch Neurol. 2012 Nov; 69 (11):1512 View PubMed Jilek S, Schluep M, Harari A, Canales M, Lysandropoulos A, Zekeridou A, Pantaleo G, Du Pasquier RA. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis. J Immunol. 2012 May 1; 188 (9):4671-80 Epub 2012 Mar 28 View PubMed PST-20480891 الصفحة الرئيسية المنشورات